3h agoGuruFocusBEARISH 34Earnings
Why Is HALEON PLC ADR (HLN) Stock Down Today?
By the Top Tier Newswire AI Desk · reviewed against 7 wire stories
HALEON PLC ADR (HLN) is down -14.85% in the latest session. Our newswire has captured 7 stories on HLN across 5 sources in the last 36 hours, with AI sentiment reading bearish (avg 36/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
The written analysis for HLN publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.
HLN by the numbers
Last: $8.52Session: -14.85%7 sessions: -1.38%Coverage: 7 stories / 5 sourcesAI sentiment: 36/100 (bearish)
The headlines behind the move
5h agoMorningstarBEARISH 28Earnings
Haleon Shares Dive After Advil Maker Cuts Guidance — 2nd Update
However, before earnings, J.P. Morgan's Celine Pannuti had said that a strong flu season could uplift sales for Haleon, with rising incidences in Europe and the U.S. "An uptick in scanner data in the U.S. and [Western] Europe has spearheaded hopes that Haleon should benefit from growth momentum in upcoming quarters," the analyst wrote.
5h agoWSJ BusinessBEARISH 34Earnings
Haleon Shares Dive After Advil Maker Cuts Guidance
Performance was held back by weaker sales in cough, cold and flu products, particularly with lower orders in North America.
5h agoInvesting.com MarketsBEARISH 32General
Why is Haleon stock plunging today?
Why is Haleon stock plunging today?
6h agoMarketWatchBEARISH 34Earnings
Haleon Cuts Guidance After Cough Medication Sales Drop -- Update
However, before earnings, J.P. Morgan's Celine Pannuti had said that a strong flu season could uplift sales for Haleon, with rising incidences in Europe and the U.S. "An uptick in scanner data in the U.S. and [Western] Europe has spearheaded hopes that Haleon should benefit from growth momentum in upcoming quarters," the analyst wrote.
6h agoMorningstarBEARISH 34Earnings
Haleon Cuts Guidance After Cough Medication Sales Drop
The company, which spun out of pharmaceutical group GSK in 2022, said it now expects full-year organic revenue growth at 2.5%. Haleon at its half-year results in July said it expected organic revenue growth of 3% to 5% for the full year.
7h agoMarketWatchBULLISH 56Earnings
Haleon 3Q Organic Revenue Growth 2.6%
Frequently asked questions
Why is HLN stock down today?
HALEON PLC ADR (HLN) is down -14.85% in the latest session. Our newswire has captured 7 stories on HLN across 5 sources in the last 36 hours, with AI sentiment reading bearish (avg 36/100). The most recent driver: "Haleon (HLN) Lowers Revenue Growth Outlook Amid Weak Cough Medicine Sales" (GuruFocus).
Is HLN a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of HLN coverage reads 36/100 over 7 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is ADT up today (+34.08%)
- Why is IOVA down today (-31.14%)
- Why is GKOS up today (+27.28%)
- Why is PRCH up today (+25.34%)
- Why is NOW down today (-24.61%)
- Why is TDOC up today (+23.26%)
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on HLN: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.